Europe’s Divisional Patent Game: How Big Pharma Avoids Final Decisions to Block Generics
Europes patent system is supposed to do two things at once: reward innovation and keep markets competitive. But a growing body of evidence suggests its doing something elsedelaying final decisions long enough for brand incumbents to keep generics waiti…
Europe’s Divisional Patent Game: How Big Pharma Avoids Final Decisions to Block Generics Read Post »
